Form 8-K - Current report:
SEC Accession No. 0000950170-24-054486
Filing Date
2024-05-07
Accepted
2024-05-07 16:10:33
Documents
61
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20240507.htm   iXBRL 8-K 42592
2 EX-99.1 rptx-ex99_1.htm EX-99.1 180152
3 EX-99.2 rptx-ex99_2.htm EX-99.2 44114
4 GRAPHIC img233743075_0.jpg GRAPHIC 13149
5 GRAPHIC rptx-ex99_2s1.jpg GRAPHIC 412361
6 GRAPHIC rptx-ex99_2s2.jpg GRAPHIC 761018
7 GRAPHIC rptx-ex99_2s3.jpg GRAPHIC 392142
8 GRAPHIC rptx-ex99_2s4.jpg GRAPHIC 355408
9 GRAPHIC rptx-ex99_2s5.jpg GRAPHIC 368198
10 GRAPHIC rptx-ex99_2s6.jpg GRAPHIC 442312
11 GRAPHIC rptx-ex99_2s7.jpg GRAPHIC 181698
12 GRAPHIC rptx-ex99_2s8.jpg GRAPHIC 367674
13 GRAPHIC rptx-ex99_2s9.jpg GRAPHIC 381193
14 GRAPHIC rptx-ex99_2s10.jpg GRAPHIC 410653
15 GRAPHIC rptx-ex99_2s11.jpg GRAPHIC 421392
16 GRAPHIC rptx-ex99_2s12.jpg GRAPHIC 369549
17 GRAPHIC rptx-ex99_2s13.jpg GRAPHIC 500213
18 GRAPHIC rptx-ex99_2s14.jpg GRAPHIC 377525
19 GRAPHIC rptx-ex99_2s15.jpg GRAPHIC 492843
20 GRAPHIC rptx-ex99_2s16.jpg GRAPHIC 375812
21 GRAPHIC rptx-ex99_2s17.jpg GRAPHIC 373151
22 GRAPHIC rptx-ex99_2s18.jpg GRAPHIC 385077
23 GRAPHIC rptx-ex99_2s19.jpg GRAPHIC 459338
24 GRAPHIC rptx-ex99_2s20.jpg GRAPHIC 405846
25 GRAPHIC rptx-ex99_2s21.jpg GRAPHIC 337090
26 GRAPHIC rptx-ex99_2s22.jpg GRAPHIC 396214
27 GRAPHIC rptx-ex99_2s23.jpg GRAPHIC 222261
28 GRAPHIC rptx-ex99_2s24.jpg GRAPHIC 311904
29 GRAPHIC rptx-ex99_2s25.jpg GRAPHIC 390711
30 GRAPHIC rptx-ex99_2s26.jpg GRAPHIC 357421
31 GRAPHIC rptx-ex99_2s27.jpg GRAPHIC 478957
32 GRAPHIC rptx-ex99_2s28.jpg GRAPHIC 356227
33 GRAPHIC rptx-ex99_2s29.jpg GRAPHIC 167493
34 GRAPHIC rptx-ex99_2s30.jpg GRAPHIC 287152
35 GRAPHIC rptx-ex99_2s31.jpg GRAPHIC 362018
36 GRAPHIC rptx-ex99_2s32.jpg GRAPHIC 403677
37 GRAPHIC rptx-ex99_2s33.jpg GRAPHIC 360064
38 GRAPHIC rptx-ex99_2s34.jpg GRAPHIC 361780
39 GRAPHIC rptx-ex99_2s35.jpg GRAPHIC 362567
40 GRAPHIC rptx-ex99_2s36.jpg GRAPHIC 329817
41 GRAPHIC rptx-ex99_2s37.jpg GRAPHIC 167424
42 GRAPHIC rptx-ex99_2s38.jpg GRAPHIC 308149
43 GRAPHIC rptx-ex99_2s39.jpg GRAPHIC 441881
44 GRAPHIC rptx-ex99_2s40.jpg GRAPHIC 363013
45 GRAPHIC rptx-ex99_2s41.jpg GRAPHIC 352913
46 GRAPHIC rptx-ex99_2s42.jpg GRAPHIC 459687
47 GRAPHIC rptx-ex99_2s43.jpg GRAPHIC 363353
48 GRAPHIC rptx-ex99_2s44.jpg GRAPHIC 276267
49 GRAPHIC rptx-ex99_2s45.jpg GRAPHIC 352956
50 GRAPHIC rptx-ex99_2s46.jpg GRAPHIC 392341
51 GRAPHIC rptx-ex99_2s47.jpg GRAPHIC 412361
  Complete submission text file 0000950170-24-054486.txt   24682510

Data Files

Seq Description Document Type Size
52 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20240507.xsd EX-101.SCH 25786
64 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20240507_htm.xml XML 4883
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 24921933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)